Discover 1,482 paid clinical trials in Greeley, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,482
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
for
Nausea, Vomiting,
Location: Fort Collins CO, Ogden UT, Fort Worth TX, Spokane WA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07169851
Phase 2, Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Fort Collins CO, Scottsdale AZ, Las Vegas NV, Tucson AZ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05006716
Phase 1, Phase 2, Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Fort Collins CO, Lone Tree CO, Farmington NM, Ogden UT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06997497
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: Fort Collins CO, Centennial CO, Colorado Springs CO,
Sponsor: Kallyope Inc.
Sex: All
Age: 18 - 70+
Code: NCT07645924
Phase 3, Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Acute Migraine
Location: Fort Collins CO, Centennial CO, Colorado Springs CO,
Sponsor: Kallyope Inc.
Sex: All
Age: 18+
Code: NCT07674654
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
for
Sjögren's Syndrome
Location: Fort Collins CO, Flagstaff AZ, Kansas City MO,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT06747949
Phase 3, Recruiting
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
for
Relapsing Multiple Sclerosis
Location: Fort Collins CO, Salt Lake City UT, Oklahoma City OK,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT05877963
Phase 3, Recruiting
Exactech Shoulder Post Market Clinical Follow-up Study